SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-320316
Filing Date
2021-11-04
Accepted
2021-11-04 16:57:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d250018ds3.htm S-3 376914
2 EX-1.2 d250018dex12.htm EX-1.2 204196
3 EX-4.4 d250018dex44.htm EX-4.4 283199
4 EX-5.1 d250018dex51.htm EX-5.1 31391
5 EX-23.1 d250018dex231.htm EX-23.1 2175
6 GRAPHIC g250018dsp117.jpg GRAPHIC 3990
7 GRAPHIC g250018dsp118.jpg GRAPHIC 6551
8 GRAPHIC g250018g37k26.jpg GRAPHIC 35044
9 GRAPHIC g250018g81u57.jpg GRAPHIC 38669
  Complete submission text file 0001193125-21-320316.txt   1015537
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260774 | Film No.: 211380906
SIC: 2836 Biological Products, (No Diagnostic Substances)